Bovie Medical Co. (NYSE:BVX) shares reached a new 52-week high during trading on Wednesday . The company traded as high as $2.65 and last traded at $2.57, with a volume of 183,974 shares changing hands. The stock had previously closed at $2.38.

BVX has been the topic of a number of recent analyst reports. JMP Securities reiterated an “outperform” rating and issued a $5.00 price objective on shares of Bovie Medical in a report on Wednesday. Zacks Investment Research upgraded Bovie Medical from a “sell” rating to a “hold” rating in a report on Wednesday, May 18th.

The stock’s market cap is $70.33 million. The stock’s 50 day moving average price is $1.84 and its 200 day moving average price is $1.84.

Bovie Medical (NYSE:BVX) last issued its earnings results on Wednesday, May 11th. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.05) by $0.02. The business had revenue of $7.80 million for the quarter, compared to the consensus estimate of $7.17 million. On average, equities research analysts expect that Bovie Medical Co. will post ($0.13) EPS for the current year.

Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.